Literature DB >> 29234913

Prediction of the histopathologic findings of intrahepatic cholangiocarcinoma: qualitative and quantitative assessment of diffusion-weighted imaging.

Sara Lewis1,2, Cecilia Besa3,4, Mathilde Wagner3,5, Kartik Jhaveri6, Shingo Kihira3, Hongfa Zhu7, Nima Sadoughi6,8, Sandra Fischer9, Amogh Srivastava10, Eric Yee11,12, Koenraad Mortele10, James Babb13, Swan Thung7, Bachir Taouli14,3.   

Abstract

OBJECTIVE: To correlate qualitative and quantitative diffusion weighted imaging (DWI) characteristics of intrahepatic cholangiocarcinoma (ICC) with histopathologic tumour grade and fibrosis content.
METHODS: Fifty-one patients (21M/30F; mean age 61y) with ICC and MRI including DWI were included in this IRB-approved multicentre retrospective study. Qualitative tumour features were assessed. Tumour apparent diffusion coefficient (ADC) mean, minimum, and normalized (nADCliver) values were computed. Tumour grade [well(G1), moderately(G2), or poorly differentiated(G3)] and tumour fibrosis content [minimal(1), moderate(2), or abundant(3)] were categorized pathologically. Imaging findings and ADC values were compared with pathologic measures. Utility of ADC values for predicting tumour grade was assessed using ROC analysis.
RESULTS: 51 ICCs (mean size 6.5±1.1 cm) were assessed. 33/51(64%) of ICCs demonstrated diffuse hyperintensity and 15/51(29%) demonstrated target appearance on DWI. Infiltrative morphology (p=0.02) and tumour size (p=0.04) were associated with G3. ADCmean and nADCmean of G3 (1.32±0.47x10-3 mm2/sec and 0.97±0.95) were lower than G1+G2 (1.57±0.39x10-3 mm2/sec and 1.24±0.49; p=0.03 and p=0.04). ADCmean and nADCmean were inversely correlated with tumour grade (p<0.025). No correlation was found between ADC and tumour fibrosis content. AUROC, sensitivity and specificity of nADCmean for G3 versus G1+G2 were 0.71, 89.5% and 55.5%.
CONCLUSION: ADC quantification has reasonable accuracy for predicting ICC grade. KEY POINTS: • ADC quantification was useful for predicting ICC tumour grade. • Infiltrative tumour morphology and size were associated with poorly differentiated ICCs. • ADC values depended more on ICC tumour grade than fibrosis content. • Ability to predict ICC tumour grade non-invasively could impact patient management.

Entities:  

Keywords:  Cholangiocarcinoma; Diffusion Magnetic Resonance Imaging; Fibrosis; Liver Neoplasms; Tumour Grading

Mesh:

Year:  2017        PMID: 29234913     DOI: 10.1007/s00330-017-5156-6

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  35 in total

1.  Chronic hepatitis and cirrhosis on MR imaging.

Authors:  Tatsuyuki Tonan; Kiminori Fujimoto; Aliya Qayyum
Journal:  Magn Reson Imaging Clin N Am       Date:  2010-08       Impact factor: 2.266

2.  Fifteen-year, single-center experience with the surgical management of intrahepatic cholangiocarcinoma: operative results and long-term outcome.

Authors:  Manousos M Konstadoulakis; Sasan Roayaie; Ilias P Gomatos; Daniel Labow; Maria-Isabell Fiel; Charles M Miller; Myron E Schwartz
Journal:  Surgery       Date:  2007-12-21       Impact factor: 3.982

Review 3.  Diffusion-weighted MR imaging of the liver.

Authors:  Bachir Taouli; Dow-Mu Koh
Journal:  Radiology       Date:  2010-01       Impact factor: 11.105

4.  The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival.

Authors:  Sae-Byeol Choi; Kyung-Sik Kim; Jin-Young Choi; Seung-Woo Park; Jin-Sub Choi; Woo-Jung Lee; Jae-Bock Chung
Journal:  Ann Surg Oncol       Date:  2009-07-22       Impact factor: 5.344

5.  "Very early" intrahepatic cholangiocarcinoma in cirrhotic patients: should liver transplantation be reconsidered in these patients?

Authors:  G Sapisochin; C Rodríguez de Lope; M Gastaca; J Ortiz de Urbina; M A Suarez; J Santoyo; J F Castroagudín; E Varo; R López-Andujar; F Palacios; G Sanchez Antolín; B Perez; A Guiberteau; G Blanco; M L González-Diéguez; M Rodriguez; M A Varona; M A Barrera; Y Fundora; J A Ferron; E Ramos; J Fabregat; R Ciria; S Rufian; A Otero; M A Vazquez; J A Pons; P Parrilla; G Zozaya; J I Herrero; R Charco; J Bruix
Journal:  Am J Transplant       Date:  2014-01-10       Impact factor: 8.086

6.  Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution.

Authors:  Michelle L DeOliveira; Steven C Cunningham; John L Cameron; Farin Kamangar; Jordan M Winter; Keith D Lillemoe; Michael A Choti; Charles J Yeo; Richard D Schulick
Journal:  Ann Surg       Date:  2007-05       Impact factor: 12.969

7.  Intrahepatic cholangiocarcinoma: analysis of 44 consecutive resected cases including 5 cases with repeat resections.

Authors:  Akio Saiura; Junji Yamamoto; Norihiro Kokudo; Rintaro Koga; Makoto Seki; Naoki Hiki; Kazuhiko Yamada; Takeshi Natori; Toshiharu Yamaguchi
Journal:  Am J Surg       Date:  2009-05-09       Impact factor: 2.565

8.  Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging.

Authors:  Tejas Parikh; Stephen J Drew; Vivian S Lee; Samson Wong; Elizabeth M Hecht; James S Babb; Bachir Taouli
Journal:  Radiology       Date:  2008-01-25       Impact factor: 11.105

9.  Preoperative grading of presumptive low-grade astrocytomas on MR imaging: diagnostic value of minimum apparent diffusion coefficient.

Authors:  E J Lee; S K Lee; R Agid; J M Bae; A Keller; K Terbrugge
Journal:  AJNR Am J Neuroradiol       Date:  2008-08-21       Impact factor: 3.825

10.  Mass-forming Intrahepatic Cholangiocarcinoma: Diffusion-weighted Imaging as a Preoperative Prognostic Marker.

Authors:  Jisun Lee; Seong Hyun Kim; Tae Wook Kang; Kyoung Doo Song; Dongil Choi; Kee Taek Jang
Journal:  Radiology       Date:  2016-04-26       Impact factor: 11.105

View more
  11 in total

1.  Diffusion-weighted imaging as an imaging biomarker for assessing survival of patients with intrahepatic mass-forming cholangiocarcinoma.

Authors:  Julaluck Promsorn; Kulyada Eurboonyanun; Payia Chadbunchachai; Chaiwat Apivatanasiri; Kosin Wirasorn; Jarin Chindaprasirt; Aumkhae Sookprasert; Mukesh Harisinghani
Journal:  Abdom Radiol (NY)       Date:  2022-06-15

2.  Liver Cancer Study Group of Japan Clinical Practice Guidelines for Intrahepatic Cholangiocarcinoma.

Authors:  Shoji Kubo; Hiroji Shinkawa; Yoshinari Asaoka; Tatsuya Ioka; Hiroshi Igaki; Namiki Izumi; Takao Itoi; Michiaki Unno; Masayuki Ohtsuka; Takuji Okusaka; Masumi Kadoya; Masatoshi Kudo; Takashi Kumada; Norihiro Kokudo; Michiie Sakamoto; Yoshihiro Sakamoto; Hideyuki Sakurai; Tadatoshi Takayama; Osamu Nakashima; Yasushi Nagata; Etsuro Hatano; Kenichi Harada; Takamichi Murakami; Masakazu Yamamoto
Journal:  Liver Cancer       Date:  2022-02-23       Impact factor: 12.430

3.  Values of MRI Imaging Presentations in the Hepatobiliary Phase, DWI and T2WI Sequences in Predicting Pathological Grades of Intrahepatic Mass-Forming Cholangiocarcinoma.

Authors:  Li-Hong Xing; Li-Yong Zhuo; Jia-Ning Wang; Yan Zhang; Feng-Ying Zhu; Chu Wang; Xiao-Ping Yin; Bu-Lang Gao
Journal:  Front Oncol       Date:  2022-06-07       Impact factor: 5.738

Review 4.  Intrahepatic cholangiocarcinoma: pathogenesis, current staging, and radiological findings.

Authors:  Mohammed Saleh; Mayur Virarkar; Vlad Bura; Raul Valenzuela; Sanaz Javadi; Janio Szklaruk; Priya Bhosale
Journal:  Abdom Radiol (NY)       Date:  2020-11

5.  Inter-observer agreement of computed tomography and magnetic resonance imaging on gross tumor volume delineation of intrahepatic cholangiocarcinoma: an initial study.

Authors:  Nan Zhou; Anning Hu; Zhihao Shi; Xiaolu Wang; Qiongjie Zhu; Qun Zhou; Jun Ma; Feng Zhao; Weiwei Kong; Jian He
Journal:  Quant Imaging Med Surg       Date:  2021-02

6.  Outcomes assessment in intrahepatic cholangiocarcinoma using qualitative and quantitative imaging features.

Authors:  Michael J King; Stefanie Hectors; Karen M Lee; Olamide Omidele; James S Babb; Myron Schwartz; Parissa Tabrizian; Bachir Taouli; Sara Lewis
Journal:  Cancer Imaging       Date:  2020-07-03       Impact factor: 3.909

7.  Primary intrahepatic cholangiocarcinoma with sarcomatous stroma: case report and review of the literature.

Authors:  Kyohei Yugawa; Tomoharu Yoshizumi; Yohei Mano; Noboru Harada; Shinji Itoh; Toru Ikegami; Yuji Soejima; Nobuhiro Fujita; Kenichi Kohashi; Shinichi Aishima; Yoshinao Oda; Masaki Mori
Journal:  Surg Case Rep       Date:  2018-11-26

8.  Prognostic prediction of resectable colorectal liver metastasis using the apparent diffusion coefficient from diffusion-weighted magnetic resonance imaging.

Authors:  Masato Yoshikawa; Yuji Morine; Shinichiro Yamada; Katsuki Miyazaki; Kazunori Tokuda; Yu Saito; Yusuke Arakawa; Tetsuya Ikemoto; Satoru Imura; Mitsuo Shimada
Journal:  Ann Gastroenterol Surg       Date:  2020-10-05

9.  A Novel Approach to Assessing Differentiation Degree and Lymph Node Metastasis of Extrahepatic Cholangiocarcinoma: Prediction Using a Radiomics-Based Particle Swarm Optimization and Support Vector Machine Model.

Authors:  Xiaopeng Yao; Xinqiao Huang; Chunmei Yang; Anbin Hu; Guangjin Zhou; Jianbo Lei; Jian Shu
Journal:  JMIR Med Inform       Date:  2020-10-05

10.  Integrated prognostication of intrahepatic cholangiocarcinoma by contrast-enhanced computed tomography: the adjunct yield of radiomics.

Authors:  Mario Silva; Michele Maddalo; Eleonora Leoni; Sara Giuliotti; Gianluca Milanese; Caterina Ghetti; Elisabetta Biasini; Massimo De Filippo; Gabriele Missale; Nicola Sverzellati
Journal:  Abdom Radiol (NY)       Date:  2021-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.